L&G Healthcare Technology & Innovation UCITS ETF USD Acc

L&G Healthcare Technology & Innovation UCITS ETF USD Acc is an equity exchange-traded fund designed to provide exposure to companies at the forefront of healthcare technology and innovation. The ETF aims to replicate the performance of the ROBO Global Healthcare Technology and Innovation Index by physically holding shares in a diversified selection of firms engaged across the healthcare technology value chain—covering areas such as medical devices, digital health, diagnostics, genomics, and biotechnology. Featuring approximately 60–66 holdings, the fund incorporates a global perspective, capturing both established and emerging players that are driving advancements in medical treatments and healthcare delivery. Established in 2019, this fund targets investors seeking access to transformative sectors within healthcare rather than traditional pharmaceutical giants. The ETF operates with an accumulating distribution policy, automatically reinvesting dividends to increase the value of each share, and applies a total expense ratio of 0.49% per year. Its market significance lies in its thematic approach—aligning with long-term trends in digital health and medical innovation—while offering the transparency, diversification, and liquidity commonly associated with UCITS-regulated ETFs.